河岡義裕 日本の研究者
Kawaoka, Yoshihiro, 1955-
河岡, 義裕
Kawaoka, Yoshihiro
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Yoshihiro Kawaoka japanischer Virologe
Kawaoka, Y.
Kawaoka, Y. (Yoshihiro), 1955-
Kawaoka, Yoshihiro, Influenza-onderzoeker
VIAF ID: 44553112 (Personal)
Permalink: http://viaf.org/viaf/44553112
Preferred Forms
-
200 _ |
‡a
Kawaoka
‡b
Yoshihiro
-
100 1 _ ‡a Kawaoka, Y.
-
100 1 _ ‡a Kawaoka, Y. ‡q (Yoshihiro), ‡d 1955-
-
100 1 _
‡a
Kawaoka, Yoshihiro
-
100 1 _ ‡a Kawaoka, Yoshihiro
-
100 1 _
‡a
Kawaoka, Yoshihiro
‡d
1955-
-
100 1 _ ‡a Kawaoka, Yoshihiro, ‡c Influenza-onderzoeker
-
100 1 _ ‡a Kawaoka, Yoshihiro, ‡d 1955-
-
100 1 _
‡a
Kawaoka, Yoshihiro,
‡d
1955-
-
100 0 _
‡a
Yoshihiro Kawaoka
‡c
japanischer Virologe
-
100 1 _
‡a
河岡, 義裕
-
100 1 _
‡a
河岡, 義裕
-
100 0 _
‡a
河岡義裕
‡c
日本の研究者
4xx's: Alternate Name Forms (19)
Works
| Title | Sources |
|---|---|
| Biology of negative strand RNA viruses, c2004: |
|
| Influenza : the cutting edge |
|
| Influenza virology : current topics |
|
| Influenza virus : methods and protocols |
|
| infuruenza kiki |
|
| Infuruenza pandemikku : Shingata uirusu no nazo ni semaru |
|
| Mōi o furuu "uirusu, kansenshō" ni dō tachimukau no ka |
|
| Neo uirusugaku. |
|
| The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. |
|
| Resistant influenza A viruses in children treated with oseltamivir: descriptive study |
|
| The Role of EGFR in Influenza Pathogenicity: Multiple Network-Based Approaches to Identify a Key Regulator of Non-lethal Infections |
|
| Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice |
|
| The role of reverse genetics systems in studying viral hemorrhagic fevers |
|
| Role of the GTPase Rab1b in ebolavirus particle formation |
|
| Round table discussion on highly pathogenic H5N1 avian influenza |
|
| The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters |
|
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo |
|
| Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus |
|
| Selective incorporation of influenza virus RNA segments into virions |
|
| [Selective packaging mechanism for influenza A virus] |
|
| Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018-2019 Influenza Season |
|
| Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study |
|
| Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan |
|
| sGP serves as a structural protein in Ebola virus infection |
|
| Significance of seasonal influenza viruses in the stool of pediatric patients |
|
| Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. |
|
| Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice |
|
| Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice |
|
| Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice |
|
| Stimulation of alpha2-adrenergic receptors impairs influenza virus infection. |
|
| Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA |
|
| Strategies for developing vaccines against H5N1 influenza A viruses. |
|
| Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography |
|
| Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle |
|
| Structure-based design of NS2 mutants for attenuated influenza A virus vaccines |
|
| Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus |
|
| Structure of influenza virus ribonucleoprotein complexes and their packaging into virions |
|
| Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018. |
|
| Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection |
|
| Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus |
|
| Synthesis of influenza virus: new impetus from an old enzyme, RNA polymerase I. |
|
| The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses |
|
| Syrian hamster as an animal model for the study of human influenza virus infection |
|
| Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection |
|
| systemsDock: a web server for network pharmacology-based prediction and analysis |
|
| T-705 (favipiravir) activity against lethal H5N1 influenza A viruses |
|
| Tatakau uirusu basutāzu : Saisentan igaku karano chōsen |
|
| Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses |
|
| Transmission of influenza A viruses |
|
| Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck |
|
| Transmission studies resume for avian flu. |
|
| Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil |
|
| Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice |
|
| Tyro3 family-mediated cell entry of Ebola and Marburg viruses |
|
| Ultracentrifugation deforms unfixed influenza A virions |
|
| Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults |
|
| Uncovering the Anti-Ebola Repertome |
|
| Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test |
|
| Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates |
|
| Villains or heroes? The raison d'être of viruses |
|
| Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice |
|
| Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. |
|
| Virological characteristics of pandemic (H1N1) 2009 influenza virus |
|
| インフルエンザパンデミック : 新型ウイルスの謎に迫る |
|
| インフルエンザ危機 |
|
| トリインフルエンザウイルスのヒトへの伝播及び病原性獲得機構 : 人工ウイルスによる分子生物学的解析 |
|
| ネオウイルス学 |
|
| リバース・ジェネティクス法によるインフルエンザ生ワクチンの開発 |
|
| 闘う!ウイルス・バスターズ : 最先端医学からの挑戦 |
|
| 新型インフルエンザ本当の姿 |
|
| 新型コロナウイルスを制圧する : ウイルス学教授が説く、その「正体」 |
|
| 猛威をふるう「ウイルス・感染症」にどう立ち向かうのか |
|
